HA

H&D Asset Management Company

Asia, T'ai-pei, Taiwan, Taipei

Description

H&D Asset Management Co. Ltd. provides property management services.

Investor Profile

H&D Asset Management Company has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does H&D Asset Management Company frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
PC
North America, Massachusetts, United States, Natick
Co-Investments: 1
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
Hercules Partners
North America, California, United States, Los Angeles
Co-Investments: 1

What are some of recent deals done by H&D Asset Management Company?

BlossomHill Therapeutics

San Diego, California, United States

BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series BJan 2, 2024
Amount Raised: $100,000,000